Biotech IPO Calendar
The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings.
The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months.
As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. Conversely, it is not uncommon to see stocks also lose over half their value.
Filter by offer date, IPO price and return to date.
As of mid-September, 2017, 37 of the 62 (60%) of Healthcare IPOs since 2016 have exhibited a positive return.
10 IPOs have shown returns of over 100% while FIVE have seen the value of their company fall by over half.
For a full list of over 450 biotech and pharma companies listed on BioPharmCatalyst we suggest you visit the Biotech Stocks page to search for your ticker of choice.
Upcoming catalysts that are often responsible for the high volatility in such stocks can be found in the BioPharmCatalyst FDA Calendar.
Data generously supplied by IPOScoop.com
Updated daily.
| Ticker | Company | Company lead managers | Shares | Estimated volume | Expected trade date |
|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | Goldman Sachs/ Jefferies | 8.8 Million | 149.6 Million | 06/22/2018 |
| ECOR | Electrocore | Evercore ISI/ Cantor/ JMP Securities | 5.2 Million | 78 Million | 06/22/2018 |
| NTGN | Neon Therapeutics | Morgan Stanley/ BofA Merrill Lynch/ Mizuho Securities | 6.25 Million | 100 Million | 06/27/2018 |
Historical IPO Database
Last 77 IPO's
| index | Ticker | Company | IPO price | Price after first day | Current price | Return | Offer date |
|---|---|---|---|---|---|---|---|
| 1 | AUTL | Autolus Therapeutics | $17.00 | N/A | N/A | 0.00% | 06/22/2018 |
| 2 | ECOR | Electrocore | $15.00 | N/A | N/A | 0.00% | 06/22/2018 |
| 3 | APTX | Aptinyx | $16.00 | $20.20 | $20.20 | 26.25% | 06/21/2018 |
| 4 | AVRO | AVROBIO | $19.00 | $31.20 | $31.20 | 64.21% | 06/21/2018 |
| 5 | KZR | Kezar Life Sciences | $15.00 | $17.75 | $17.75 | 18.33% | 06/21/2018 |
| 6 | MGTA | Magenta Therapeutics | $15.00 | $14.52 | $14.52 | -3.20% | 06/21/2018 |
| 7 | XERS | Xeris Pharmaceuticals | $15.00 | $20.22 | $20.22 | 34.80% | 06/21/2018 |
| 8 | EIDX | Eidos Therapeutics | $17.00 | $23.12 | $21.94 | 29.06% | 06/20/2018 |
| 9 | VRCA | Verrica Pharmaceuticals | $15.00 | $17.50 | $20.06 | 33.73% | 06/15/2018 |
| 10 | MGTX | MeiraGTx Holdings plc | $15.00 | $15.00 | $12.79 | -14.73% | 06/08/2018 |
| 11 | HJLI | Hancock Jaffe Laboratories | $5.00 | $5.20 | $4.45 | -11.00% | 05/31/2018 |
| 12 | ITRM | Iterum Therapeutics plc | $13.00 | $12.85 | $12.00 | -7.69% | 05/25/2018 |
| 13 | KNSA | Kiniksa Pharmaceuticals, Ltd. | $18.00 | $19.47 | $19.25 | 6.94% | 05/24/2018 |
| 14 | SRRK | Scholar Rock Holding | $14.00 | $15.50 | $23.17 | 65.50% | 05/24/2018 |
| 15 | EVLO | Evelo Biosciences | $16.00 | $16.25 | $13.72 | -14.25% | 05/09/2018 |
| 16 | ASLN | ASLAN Pharmaceuticals Ltd. | $7.03 | $5.61 | $8.45 | 20.20% | 05/04/2018 |
| 17 | INSP | Inspire Medical Systems | $16.00 | $24.98 | $39.12 | 144.50% | 05/03/2018 |
| 18 | UBX | Unity Biotechnology | $17.00 | $16.65 | $14.79 | -13.00% | 05/03/2018 |
| 19 | SURF | Surface Oncology | $15.00 | $13.33 | $15.54 | 3.60% | 04/19/2018 |
| 20 | MOR | MorphoSys AG | $25.04 | $26.31 | N/A | 0.00% | 04/19/2018 |
| 21 | GNPX | Genprex | $5.00 | $4.70 | $7.91 | 58.20% | 03/29/2018 |
| 22 | UMRX | Unum Therapeutics | $12.00 | $11.11 | $13.83 | 15.25% | 03/29/2018 |
| 23 | FIXX | Homology Medicines | $16.00 | $18.66 | $19.81 | 23.81% | 03/28/2018 |
| 24 | RCUS | Arcus Biosciences | $15.00 | $17.00 | $16.02 | 6.80% | 03/15/2018 |
| 25 | BTAI | BioXcel Therapeutics | $11.00 | $11.03 | $9.08 | -17.45% | 03/08/2018 |
| 26 | BFRA | Biofrontera AG | $9.88 | $12.18 | $12.18 | 23.28% | 02/14/2018 |
| 27 | MOTS | Motus GI Holdings | $5.00 | $4.38 | $6.35 | 27.00% | 02/14/2018 |
| 28 | EOLS | Evolus | $12.00 | $11.50 | $31.94 | 166.17% | 02/08/2018 |
| 29 | SLGL | Sol-Gel Technologies | $12.00 | $13.64 | $7.87 | -34.42% | 02/01/2018 |
| 30 | ARMO | ARMO BioSciences | $17.00 | $29.74 | $49.98 | 194.00% | 01/26/2018 |
| 31 | TORC | resTORbio | $15.00 | $16.88 | $10.53 | -29.80% | 01/26/2018 |
| 32 | SLDB | Solid Biosciences | $16.00 | $22.62 | $42.34 | 164.63% | 01/26/2018 |
| 33 | EYEN | Eyenovia | $10.00 | N/A | $8.03 | -19.70% | 01/25/2018 |
| 34 | MNLO | Menlo Therapeutics | $17.00 | $28.71 | $8.00 | -52.94% | 01/25/2018 |
| 35 | DNLI | Denali Therapeutics | $18.00 | $21.45 | $17.00 | -5.56% | 12/08/2017 |
| 36 | ODT | Odonate Therapeutics | $24.00 | $23.00 | $24.82 | 3.42% | 12/07/2017 |
| 37 | QTRX | Quanterix | $15.00 | $17.47 | $15.89 | 5.93% | 12/07/2017 |
| 38 | SCPH | scPharmaceuticals | $14.00 | $14.10 | $5.56 | -60.29% | 11/17/2017 |
| 39 | ASNS | Arsanis | $10.00 | $14.03 | $16.53 | 65.30% | 11/16/2017 |
| 40 | APLS | Apellis Pharmaceuticals | $14.00 | $14.03 | $21.95 | 56.79% | 11/09/2017 |
| 41 | IFRX | Fireman B.V. | $15.00 | $14.99 | $30.99 | 106.60% | 11/08/2017 |
| 42 | ALNA | Allena Pharmaceuticals | $14.00 | $9.98 | $13.00 | -7.14% | 11/02/2017 |
| 43 | SPRO | Spero Therapeutics | $14.00 | $13.25 | $13.30 | -5.00% | 11/02/2017 |
| 44 | EYE | National Vision Holdings | $22.00 | $27.83 | $38.86 | 76.64% | 10/26/2017 |
| 45 | OPTN | OptiNose | $16.00 | $19.00 | $25.01 | 56.31% | 10/13/2017 |
| 46 | KIDS | OrthoPediatrics | $13.00 | $19.72 | $26.55 | 104.23% | 10/12/2017 |
| 47 | HAIR | Restoration Robotics | $7.00 | $9.92 | $2.73 | -61.00% | 10/12/2017 |
| 48 | RYTM | Rhythm Pharmaceuticals | $17.00 | $30.00 | $32.91 | 93.59% | 10/05/2017 |
| 49 | NCNA | NuCana plc | $15.00 | $16.15 | $23.52 | 56.80% | 09/28/2017 |
| 50 | DCPH | Deciphera Pharmaceuticals | $17.00 | $17.65 | $44.95 | 164.41% | 09/28/2017 |
| 51 | NITE | Nightstar Therapeutics Ltd. | $14.00 | $24.00 | $15.08 | 7.71% | 09/28/2017 |
| 52 | CELC | Celcuity | $9.50 | $14.29 | $21.53 | 126.63% | 09/20/2017 |
| 53 | KRYS | Krystal Biotech | $10.00 | $10.64 | $14.04 | 40.40% | 09/20/2017 |
| 54 | ZLAB | Zai Lab Ltd. | $18.00 | $27.93 | $23.44 | 30.22% | 09/20/2017 |
| 55 | CMTA | Clementia Pharmaceuticals | $15.00 | $16.35 | $14.41 | -3.93% | 08/02/2017 |
| 56 | SNNA | Sienna Biopharmaceuticals | $15.00 | $19.25 | $15.58 | 3.87% | 07/27/2017 |
| 57 | PETQ | PetIQ | $16.00 | $23.32 | $23.96 | 49.75% | 07/21/2017 |
| 58 | KALA | Kala Pharmaceuticals | $15.00 | $18.49 | $13.94 | -7.07% | 07/20/2017 |
| 59 | AKCA | Akcea Therapeutics | $8.00 | $9.48 | $25.92 | 224.00% | 07/14/2017 |
| 60 | CODX | Co-Diagnostics | $6.00 | $5.81 | $3.78 | -37.00% | 07/12/2017 |
| 61 | ALRN | Aileron Therapeutics | $15.00 | $10.80 | $6.02 | -59.87% | 06/29/2017 |
| 62 | DOVA | Dova Pharmaceuticals | $17.00 | $19.81 | $30.07 | 76.88% | 06/29/2017 |
| 63 | MRSN | Mersana Therapeutics | $15.00 | $14.00 | $18.65 | 24.33% | 06/28/2017 |
| 64 | ATXI | Avenue Therapeutics | $6.00 | $8.25 | $3.91 | -34.83% | 06/27/2017 |
| 65 | ATNX | Athenex | $11.00 | $12.56 | $18.62 | 69.27% | 06/14/2017 |
| 66 | GTHX | G1 Therapeutics | $15.00 | $15.00 | $49.37 | 229.13% | 05/17/2017 |
| 67 | OVID | Ovid Therapeutics | $15.00 | $12.25 | $8.15 | -45.67% | 05/05/2017 |
| 68 | URGN | UroGen Pharma Ltd. | $13.00 | $13.98 | $54.82 | 321.69% | 05/04/2017 |
| 69 | BHVN | Biohaven Pharmaceutical Holding | $17.00 | $17.50 | $40.15 | 136.18% | 05/04/2017 |
| 70 | ZYME | Zymeworks | $13.00 | $13.00 | $16.11 | 23.92% | 04/28/2017 |
| 71 | TOCA | Tocagen | $10.00 | $12.45 | $8.98 | -10.20% | 04/13/2017 |
| 72 | BYSI | BeyondSpring | $20.00 | $16.80 | $26.50 | 32.50% | 03/09/2017 |
| 73 | JNCE | Jounce Therapeutics | $16.00 | $17.25 | $8.15 | -49.06% | 01/27/2017 |
| 74 | ANAB | AnaptysBio | $15.00 | $17.00 | $71.55 | 377.00% | 01/26/2017 |
| 75 | OBSV | ObsEva SA | $15.00 | $11.65 | $14.93 | -0.47% | 01/26/2017 |
| 76 | SBPH | Spring Bank Pharmaceuticals | $12.00 | $11.10 | $12.01 | 0.08% | 05/06/2016 |
| 77 | GI | EndoChoice Holdings (ECPM Holdings) | $15.00 | $17.00 | $0.02 | -99.87% | 06/05/2015 |